Create Profile

Creating your profile will enable you to submit photos and stories to get published on News24.

Please provide a username for your profile page:

This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire 24.com network.

Facebook Sign-In

Hi News addict,

Join the News24 Community to be involved in breaking the news.

Log in with Facebook to comment and personalise news, weather and listings.


EU scheme commits $350 mln for Ebola research

06 November 2014, 19:25

London - The Europe Union and drugmakers pledged on Thursday to invest 280 million euros ($350 million) in Ebola research, with the lion's share going to the testing and manufacture of potential vaccines.

The funding will go to projects backed by the Innovative Medicines Initiative (IMI), a public-private scheme jointly paid for by the European Commission and the pharmaceuticals industry.

Reuters reported on Oct. 22 that an IMI investment of around 200 million euros was pending. Since then, further discussions have been held about the resources needed for various projects and the amount has been increased.

Also read: Obama to request $6bn for Ebola crisis

The final document setting out the plans commits the European Commission to giving as much as 140 million euros, with companies providing an equivalent amount in staff time, goods and services.

"The EU is determined to help find a solution to Ebola. We are putting our money where our mouth is and boosting EU research on Ebola with an additional 280 million euros," said Carlos Moedas, European Commissioner for research.

The move shows how momentum is building to get medical intervention, especially vaccines, to West Africa as soon as possible, to try to control the world's worst Ebola outbreak, which has killed nearly 5,000 people, according to official data. Many experts believe the true death toll is a lot higher.

The EU is also beginning its biggest single operation of transporting supplies to West Africa, with a Dutch ship sailing on Thursday from the Netherlands, loaded with ambulances, mobile hospitals, laboratories and other equipment provided by nine European countries.

Five priority projects

With a total budget of 3.3 billion euros for the period 2014 to 2024, Europe's IMI scheme is the world's biggest public-private partnership in life sciences.

It began in 2008 and now has 46 ongoing projects, some of which are focused on specific health issues such as Alzheimer's disease, cancer and obesity. Others involve work on broader challenges in drug development.

In the case of Ebola, five urgent projects have been identified involving the three stages of vaccine clinical trials; vaccine manufacturing; vaccine transport and storage; regimens for vaccination deployment; and rapid diagnostic tests.

The aim is to head off some of the technical obstacles that public health officials, governments and drug-makers face as they try to develop the world's first Ebola vaccines in record time.

The challenges include finding enough vaccine manufacturing and filling capacity, getting accelerated clinical trial results, winning rapid regulatory approvals and building a supply chain in Africa for products that must be stored at ultra-low temperatures.

For diagnostics, the goal is to develop a simple test for Ebola infection that can generate results within three hours and preferably in less than 30 minutes.

Two leading vaccine candidates from GlaxoSmithKline and NewLink Genetics are already in human safety trials. Another five should begin testing in the first quarter of next year. One from Johnson & Johnson will start trials in January.

The three leading companies hope to make millions of doses over the course of 2015.

- Reuters

Tags eu london ebola

Read News24’s Comments Policy

Comment on this story
Comments have been closed for this article.

Read more from our Users

Nigeria @ 56: Words to my green f...

A leader’s job is not to dictate, but rather to be respected, admired and be a trustee, of the land we love, with so much potential, a land which should be freer than free. Its still a long way to fufilling our destiny! Read more...

Submitted by
Isaac Asabor263
Recession: An opportunity for Nig...

The recession should be seen as an opportunity for the country’s promotion as long as we all collectively conduct ourselves in a patriotic manner, writes Isaac Asabor.  Read more...

Submitted by
Black and White

We want to imitate the whites in everything because we are ignorant of our inherent originality and content. We spend all our Naira to acquire his inventions because we so oblivious of our natural endowments that we allow him have it for free. Read more...

Submitted by
Nate Nat
Adamawa State University Mubi: A ...

ADSU integrity forum has accused the Sunday Joshua Wugira, a lawyer, of adopting unorthodox tactics by abusing his privilege by attacking the integrity of ADSU Vice Chancellor Dr. Moses Zira Zaruwa, writes a News24 reader. Read more...

Submitted by
Abdulsalam Jubril
My Country Nigeria (Part One)

Poetry by Abdulsalam Jubril.

Submitted by
Abdulsalam Jubril
Recession, dearth in leadership a...

Every leader has the opportunity to become great and making himself immortal in the lives and hearts of people for generations to come. Will Mr. President seize this opportunity?, questions Abdulsalam Jubril. Read more...